Statement Of Financial Position [Abstract]

GenSight Biologics S.A. - Filing #5982864

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Intangible assets other than goodwill
57,000 EUR
75,000 EUR
Other non-current financial assets
4 424 EUR
502,000 EUR
Non-current assets
5 413 EUR
2,603,000 EUR
Current assets [abstract]
Cash and cash equivalents
2 464 EUR
2,134,000 EUR
10,610,000 EUR
Current assets
5 343 EUR
6,529,000 EUR
Assets
10 756 EUR
9,132,000 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
3 119 EUR
1,633,000 EUR
Share premium
206 606 EUR
190,937,000 EUR
Equity
206 606 EUR
26 920 EUR
3 119 EUR
222 644 EUR
14 001 EUR
190,937,000 EUR
1,633,000 EUR
30,702,000 EUR
197,051,000 EUR
26,220,000 EUR
15,279,000 EUR
181,211,000 EUR
170,024,000 EUR
1,158,000 EUR
27,625,000 EUR
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current provisions [abstract]
Non-current provisions for employee benefits
1 166 EUR
1,258,000 EUR
Non-current liabilities
15 058 EUR
14,543,000 EUR
Current liabilities [abstract]
Current provisions [abstract]
Current provisions
0 EUR
0 EUR
Current liabilities
22 618 EUR
25,290,000 EUR
Equity and liabilities
10 756 EUR
9,132,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.